Zobrazeno 1 - 10
of 123
pro vyhledávání: '"James D. Chambers"'
Publikováno v:
Health Policy Open, Vol 5, Iss , Pp 100103- (2023)
Growth in the availability of cell and gene therapies (CGTs) promises significant innovation in the treatment of serious diseases, but the high cost and one-time administration of CGTs has also raised concern about strain on health plan budgets and i
Externí odkaz:
https://doaj.org/article/75d64e16c55e4fcbafa04d5bdac9008a
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-10 (2022)
Abstract Background The extent to which different US private insurers require their enrollees to meet the same coverage criteria before gaining access to treatment is unclear. Our objective was to scrutinize the patient access criteria imposed by US
Externí odkaz:
https://doaj.org/article/e9c35cad7d0444c392984cb0ef0d8801
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:472-479
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:464-471
Autor:
James D Chambers, Daniel E Enright, Ari D Panzer, Josh T Cohen, Daniel A Ollendorf, Peter J Neumann
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:257-264
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:1053-1058
Autor:
Lauren A. Do, Benjamin C. Koethe, Allan T. Daly, James D. Chambers, Daniel A. Ollendorf, John B. Wong, A. Mark Fendrick, Peter J. Neumann, David D. Kim
Publikováno v:
Health Affairs. 41:1281-1290
Autor:
Christine Learned, Sara Alsukait, Kristin R Fiumara, Melissa Ortega, James D Chambers, David Rosmarin
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 7:160-163
Background Specialty medications provide effective treatment with limited adverse effects to patients with psoriasis and psoriatic arthritis; however, variable coverage and high costs often create a barrier to treatment for patients with commercial h
Publikováno v:
BioDrugs.
Publikováno v:
Alzheimer's & Dementia.